| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 8, 2026 | Option exercise(M) | 49K | $23.98 | $1.2M | 161K |
| Apr 8, 2026 | Option exercise(M) | 10K | $20.02 | $193K | 171K |
| Apr 8, 2026 | Option exercise(M) | 19K | $19.64 | $380K | 190K |
| Apr 8, 2026 | Sell(S) | 85K | $40.10 | $3.4M | 105K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 8, 2026 | Option exercise(M) | 49K | — | $0 | 63K |
| Apr 8, 2026 | Option exercise(M) | 10K | — | $0 | 11K |
| Apr 8, 2026 | Option exercise(M) | 19K | — | $0 | 66K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-024716) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Crinetics Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.